What is the lead time for orders?

The average lead time is within 15 workdays for both peak and off-season periods.

Fully Automated 3-Part Hematology Analyzer with Touch Screen

Name: Fully Automated 3-Part Hematology Analyzer with Touch Screen
Brand: Rayland Medical Co., Ltd
SKU: 2128752372

Tianjin, ChinaRayland Medical Co., Ltd

US$1,300.00-1,500.00

1 Piece

Product profile

Customization

Available

Classification

Physiological Functions of Diagnosis and Monitoring Equipment

Type

Hematology Analyzer

Model NO.

Hematology Analyzer

Certification

Group

All

Transport Package

Box

Trademark

Rayland

Origin

China

Production Capacity

10000

Key features

8.4'' Touch Screen Interface: Features an 8.4-inch LCD touch screen with full Chinese color operation interface and graphical buttons.

High-Speed Detection: Achieves a detection speed of 60 samples per hour with automated dilution and flushing functions.

Comprehensive 23 Parameters: Provides WBC three-part grouping and 23 parameters including WBC, RBC, PLT, and histograms.

Environmentally Friendly Principle: Uses electrical impedance method without cyanide for hemoglobin detection, ensuring safety.

Large Data Storage: Stores over 10,000 samples with infinite expansion capability via USB connection.

Flexible Sample Input: Supports venous blood, anticoagulant peripheral blood, and diluted peripheral blood injection methods.

CE Certified Quality: Meets CE certification standards for reliable performance in clinical laboratories and exam centers.

Fast Response Lead Time: Offers an average lead time of within 15 workdays for both peak and off-season orders.

Company profile

Rayland Medical Co., LtdTianjin, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2025-02-01Nearest Port: Tianjin Port, Shenzhen PortAverage Response Time: ≤9.37hTerms of Payment: T/T, PayPalInternational Commercial Terms(Incoterms): FOB, EXW, CIF, CFR, DDP

AI-Powered supplier vetting

SummaryRayland Medical Co., Ltd is a China-based limited company in Tianjin operating as both a trading company and manufacturer/factory in the health and medicine sector. It holds ISO 9001 certification, operates five production lines, reports 6–10 quality-control staff and 6–10 years of R&D-engineer experience, and recorded 20,000 pieces of annual production in 2024. The supplier states that it has served Chinese public hospitals for approximately two decades and names Tianjin Medical University General Hospital and Tianjin First Central Hospital as domestic clients. It exports to a broad range of global markets, with exports representing 90% of total sales, and reports order fulfillment within 15 workdays in both peak and off-peak seasons. Evidence is insufficient to assess after-sales service, customization, and financial credibility; the available production information supports production capability, while the stated product keywords and R&D staffing provide only limited evidence for innovation capability.

Supplier typeRayland Medical is explicitly identified as both a trading company and a manufacturer/factory. It is a China-based limited company operating in health and medicine, indicating a combined manufacturing and trading structure.

CertificationsThe supplier reports holding ISO 9001 certification for its management system. This is explicit evidence of a formal quality-management certification, although no certification scope or validity period is provided.

Production capacityRayland Medical reports five production lines, 6–10 quality-control staff, and 20,000 pieces of annual production in 2024. It also states that orders can be fulfilled within 15 workdays during both peak and off-peak seasons, providing explicit evidence of established production operations and stated delivery capacity.

Client casesThe supplier states that it has supplied medical consumables to Chinese public hospitals for the past two decades and identifies Tianjin Medical University General Hospital and Tianjin First Central Hospital as domestic clients. These named institutional customers provide explicit customer-case evidence, although no contract scope, product details, or performance metrics are given.